Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation-百迪生物科技

首页 > 文献支持 > Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation

Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation

2025-09-15·文献支持

加入收藏去分享

发布日期： 2025-09-15

来源：

作者： Xier Pan, Xinyi Chen, Ying Ma, Jiafeng Zou, Yiting Lin, Xinlin Zhao, Yanwen Wang, Yun Tang, Feng Gao

加入收藏去分享

来源网址：https://www.sciencedirect.com/science/article/abs/pii/S0142961225006131?via%3Dihub

期刊：Biomaterials丨丨引用百迪产品：H805038 40μm细胞滤网

IF：12.9

日期：2025-09-15

Monocyte/macrophage-derived interleukin-15 mediates the pro-inflammatory phenotype of CD226+ B cells in type 1 diabetes

日期：2025-09-12

Dynamic ROS-responsive hyperbranched polymer-based neuroprotective drug delivery system for pathogenesis-adaptive sequential therapy of cerebral ischemic stroke

解决方案

关于百迪